Noosa News
Wonder drug killing dog cancers
QBiotics has just received FDA approval for the distribution of the veterinary treatment in the US and it is already in use in the UK and across Europe. “We hope to have approval for the pharmaceutical Tigilanol tiglate branded as Stelfonta for canine mast cell tumours to be available to vets in mid 2021,” chief executive Victoria Gordon said.Clinical trials show that 75 per cent of dogs treated with a single injection were cured and 88 per cent of the dogs who needed two injections were cured.
…
Click here to view the original article.
-
Noosa News13 hours agoCrucial step in Sea World helicopter crash investigation set
-
Business13 hours agoWhy Accent, DroneShield, EBR Systems, and Titomic shares are pushing higher
-
Noosa News19 hours agoLocal input into new UN treaty – Proctor
-
Business18 hours agoIs the Qantas share price a buy in the tariff ASX stock market volatility?